Mead Johnson's Transition to Packaging Materials Without BPA
On January 15, 2009, the U.S. Food and Drug Administration (FDA) reaffirmed the safety of BPA for use in all food contact applications - including infant formula packaging. » Read More
Information About Perchlorate
Recent media attention has focused on the presence of trace levels of perchlorate in powdered infant formula. The quality and safety of our products are our highest priority. » Read More
Mead Johnson Nutrition Announces Closing of IPO
Mead Johnson Nutrition Company (NYSE: MJN) today said that it has closed its previously announced initial public offering of 30 million shares of Class A common stock at the public offering price of $24 per share. » Read More
Mead Johnson Nutrition Prices Initial Public Offering
Mead Johnson Nutrition Company today announced that its initial public offering of Class A common stock has been priced at $24.00 per share. » Read More
Helpful Information about Melamine and Cyanuric Acid
Mead Johnson remains confident in the safety of our products and wants to provide helpful information for you. » Read More
Mead Johnson Begins Construction on New Research and Development Technology Center
Mead Johnson Nutrition broke ground today for a $26.2 million Global Research and Development Technology Center that will further strengthen the company's innovation processes as well as Southwestern Indiana's biotechnology presence. » Read More
The U.S. FDA Reaffirms the Safety of Enfamil® Infant Formula
The U.S. Food and Drug Administration (FDA) has confirmed that no melamine has been detected in Enfamil infant formula products and that recent media reports indicating that trace levels had been detected were inaccurate. » Read More
